MediObserve

PV ANALYTICA

About this app

MediObserve is an AI-powered mobile application developed by PV Analytica to help patients, caregivers, and healthcare professionals securely capture and share their experiences with medicines and medical products. Whether you’re reporting an adverse event, requesting information about a product, or providing structured feedback, MediObserve’s intelligent smart assistant is here to support you 24/7.

Powered by Responsible AI, MediObserve uses a domain-specific virtual assistant trained on validated pharmacovigilance and medical datasets. It guides you through a structured pathway in a conversational, easy-to-use format.

Key Features:

• Record Adverse Event (AEs) Information: Document safety-related information about drugs in a structured, regulator-ready format.

• Submit Medical Inquiries (MI): Ask general questions about medicines, which are either addressed with reference information or routed to qualified medical affairs teams.

• Secure Digital Consent: Provide eConsent in compliance with global data protection laws.

• Multilingual Support: Record information in your local language with secure translation.

• Compliance by Design: Built to align with HIPAA, GDPR, FDA 21 CFR Part 11, and ICH E2B(R3) standards.

Who Can Use MediObserve?

• Patients and caregivers: Record side effects and request general medical information.

• Healthcare professionals: Record safety data on behalf of patients or request product information.

• Clinical researchers and pharma teams: Access standardized safety data with full traceability.

Why MediObserve?

• Faster and easier than forms or call centers

• Ensures complete, structured safety data

• 24/7 availability

• User-friendly, conversational interface

Disclaimer: MediObserve does not provide medical advice, diagnosis, or treatment. It is intended for user reporting and educational purposes only. Always seek the advice of a qualified healthcare professional with any questions you may have regarding a medical condition.

What’s new

Minor Changes